<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-08-01" modified="2020-10-07" version="191">
<accession>P26651</accession>
<accession>B2RA54</accession>
<name>TTP_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="44">mRNA decay activator protein ZFP36</fullName>
</recommendedName>
<alternativeName>
<fullName>G0/G1 switch regulatory protein 24</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="44">Growth factor-inducible nuclear protein NUP475</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="43">Tristetraprolin</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="45">Zinc finger protein 36</fullName>
<shortName evidence="4">Zfp-36</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="45">ZFP36</name>
<name type="synonym">G0S24</name>
<name type="synonym" evidence="4">NUP475</name>
<name type="synonym">RNF162A</name>
<name type="synonym">TIS11A</name>
<name type="synonym" evidence="43">TTP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Nucleic Acids Res." volume="19" first="3454" last="3454">
<title>The human TTP protein: sequence, alignment with related proteins, and chromosomal localization of the mouse and human genes.</title>
<authorList>
<person name="Taylor G.A."/>
<person name="Lai W.S."/>
<person name="Oakey R.J."/>
<person name="Seldin M.F."/>
<person name="Shows T.B."/>
<person name="Eddy R.L. Jr."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="2062660"/>
<dbReference type="DOI" id="10.1093/nar/19.12.3454"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-37; PHE-259 AND PHE-324</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Science" volume="281" first="1001" last="1005">
<title>Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.</title>
<authorList>
<person name="Carballo E."/>
<person name="Lai W.S."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="9703499"/>
<dbReference type="DOI" id="10.1126/science.281.5379.1001"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="4311" last="4323">
<title>Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.</title>
<authorList>
<person name="Lai W.S."/>
<person name="Carballo E."/>
<person name="Strum J.R."/>
<person name="Kennington E.A."/>
<person name="Phillips R.S."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="10330172"/>
<dbReference type="DOI" id="10.1128/mcb.19.6.4311"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-124 AND CYS-147</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="17827" last="17837">
<title>Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA.</title>
<authorList>
<person name="Lai W.S."/>
<person name="Carballo E."/>
<person name="Thorn J.M."/>
<person name="Kennington E.A."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="10751406"/>
<dbReference type="DOI" id="10.1074/jbc.m001696200"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Cell" volume="107" first="451" last="464">
<title>AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.</title>
<authorList>
<person name="Chen C.-Y."/>
<person name="Gherzi R."/>
<person name="Ong S.-E."/>
<person name="Chan E.L."/>
<person name="Raijmakers R."/>
<person name="Pruijn G.J.M."/>
<person name="Stoecklin G."/>
<person name="Moroni C."/>
<person name="Mann M."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="11719186"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00578-5"/>
</citation>
<scope>FUNCTION</scope>
<scope>ASSOCIATION WITH THE RNA EXOSOME COMPLEX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="23144" last="23154">
<title>Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail.</title>
<authorList>
<person name="Lai W.S."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="11279239"/>
<dbReference type="DOI" id="10.1074/jbc.m100680200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Arthritis Rheum." volume="46" first="1362" last="1370">
<title>Analysis of the function, expression, and subcellular distribution of human tristetraprolin.</title>
<authorList>
<person name="Brooks S.A."/>
<person name="Connolly J.E."/>
<person name="Diegel R.J."/>
<person name="Fava R.A."/>
<person name="Rigby W.F."/>
</authorList>
<dbReference type="PubMed" id="12115244"/>
<dbReference type="DOI" id="10.1002/art.10235"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Natl. Cancer Inst." volume="95" first="1846" last="1859">
<title>Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression.</title>
<authorList>
<person name="Twizere J.-C."/>
<person name="Kruys V."/>
<person name="Lefebvre L."/>
<person name="Vanderplasschen A."/>
<person name="Collete D."/>
<person name="Debacq C."/>
<person name="Lai W.S."/>
<person name="Jauniaux J.-C."/>
<person name="Bernstein L.R."/>
<person name="Semmes J.O."/>
<person name="Burny A."/>
<person name="Blackshear P.J."/>
<person name="Kettmann R."/>
<person name="Willems L."/>
</authorList>
<dbReference type="PubMed" id="14679154"/>
<dbReference type="DOI" id="10.1093/jnci/djg118"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="3798" last="3812">
<title>Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease.</title>
<authorList>
<person name="Lai W.S."/>
<person name="Kennington E.A."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="12748283"/>
<dbReference type="DOI" id="10.1128/mcb.23.11.3798-3812.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF CYS-124</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="315" first="445" last="449">
<title>Direct association of tristetraprolin with the nucleoporin CAN/Nup214.</title>
<authorList>
<person name="Carman J.A."/>
<person name="Nadler S.G."/>
</authorList>
<dbReference type="PubMed" id="14766228"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.01.080"/>
</citation>
<scope>INTERACTION WITH NUP214</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="1313" last="1324">
<title>MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.</title>
<authorList>
<person name="Stoecklin G."/>
<person name="Stubbs T."/>
<person name="Kedersha N."/>
<person name="Wax S."/>
<person name="Rigby W.F."/>
<person name="Blackwell T.K."/>
<person name="Anderson P."/>
</authorList>
<dbReference type="PubMed" id="15014438"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600163"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Immunol." volume="172" first="7263" last="7271">
<title>The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.</title>
<authorList>
<person name="Brooks S.A."/>
<person name="Connolly J.E."/>
<person name="Rigby W.F."/>
</authorList>
<dbReference type="PubMed" id="15187101"/>
<dbReference type="DOI" id="10.4049/jimmunol.172.12.7263"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Cell" volume="120" first="623" last="634">
<title>Involvement of microRNA in AU-rich element-mediated mRNA instability.</title>
<authorList>
<person name="Jing Q."/>
<person name="Huang S."/>
<person name="Guth S."/>
<person name="Zarubin T."/>
<person name="Motoyama A."/>
<person name="Chen J."/>
<person name="Di Padova F."/>
<person name="Lin S.C."/>
<person name="Gram H."/>
<person name="Han J."/>
</authorList>
<dbReference type="PubMed" id="15766526"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.12.038"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AGO2 AND AGO4</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="351" last="361">
<title>Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1.</title>
<authorList>
<person name="Lykke-Andersen J."/>
<person name="Wagner E."/>
</authorList>
<dbReference type="PubMed" id="15687258"/>
<dbReference type="DOI" id="10.1101/gad.1282305"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A MRNA DECAY ACTIVATION COMPLEX</scope>
<scope>INTERACTION WITH CNOT6; DCP1A; DCP2; EXOSC2 AND XRN1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Immunol." volume="174" first="953" last="961">
<title>Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.</title>
<authorList>
<person name="Ogilvie R.L."/>
<person name="Abelson M."/>
<person name="Hau H.H."/>
<person name="Vlasova I."/>
<person name="Blackshear P.J."/>
<person name="Bohjanen P.R."/>
</authorList>
<dbReference type="PubMed" id="15634918"/>
<dbReference type="DOI" id="10.4049/jimmunol.174.2.953"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Mol. Cell" volume="20" first="905" last="915">
<title>Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping.</title>
<authorList>
<person name="Fenger-Groen M."/>
<person name="Fillman C."/>
<person name="Norrild B."/>
<person name="Lykke-Andersen J."/>
</authorList>
<dbReference type="PubMed" id="16364915"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.10.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DCP2 AND EDC3</scope>
<scope>MUTAGENESIS OF PHE-126</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Nucleic Acids Res." volume="33" first="4813" last="4827">
<title>Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR.</title>
<authorList>
<person name="Linker K."/>
<person name="Pautz A."/>
<person name="Fechir M."/>
<person name="Hubrich T."/>
<person name="Greeve J."/>
<person name="Kleinert H."/>
</authorList>
<dbReference type="PubMed" id="16126846"/>
<dbReference type="DOI" id="10.1093/nar/gki797"/>
</citation>
<scope>INTERACTION WITH KHSRP</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Biochem. J." volume="394" first="285" last="297">
<title>Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis.</title>
<authorList>
<person name="Cao H."/>
<person name="Deterding L.J."/>
<person name="Venable J.D."/>
<person name="Kennington E.A."/>
<person name="Yates J.R. III"/>
<person name="Tomer K.B."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="16262601"/>
<dbReference type="DOI" id="10.1042/bj20051316"/>
</citation>
<scope>PHOSPHORYLATION AT SER-66; SER-88; THR-92; SER-169; SER-186; SER-197; SER-218; SER-228; SER-276 AND SER-296</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="2408" last="2418">
<title>Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways.</title>
<authorList>
<person name="Brook M."/>
<person name="Tchen C.R."/>
<person name="Santalucia T."/>
<person name="McIlrath J."/>
<person name="Arthur J.S."/>
<person name="Saklatvala J."/>
<person name="Clark A.R."/>
</authorList>
<dbReference type="PubMed" id="16508015"/>
<dbReference type="DOI" id="10.1128/mcb.26.6.2408-2418.2006"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="9196" last="9208">
<title>Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.</title>
<authorList>
<person name="Lai W.S."/>
<person name="Parker J.S."/>
<person name="Grissom S.F."/>
<person name="Stumpo D.J."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="17030620"/>
<dbReference type="DOI" id="10.1128/mcb.00945-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF CYS-124</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="6277" last="6290">
<title>Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.</title>
<authorList>
<person name="Marderosian M."/>
<person name="Sharma A."/>
<person name="Funk A.P."/>
<person name="Vartanian R."/>
<person name="Masri J."/>
<person name="Jo O.D."/>
<person name="Gera J.F."/>
</authorList>
<dbReference type="PubMed" id="16702957"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209645"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH 14-3-3 PROTEINS</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="719" last="735">
<title>TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements.</title>
<authorList>
<person name="Franks T.M."/>
<person name="Lykke-Andersen J."/>
</authorList>
<dbReference type="PubMed" id="17369404"/>
<dbReference type="DOI" id="10.1101/gad.1494707"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-124</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="RNA" volume="14" first="888" last="902">
<title>Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation.</title>
<authorList>
<person name="Emmons J."/>
<person name="Townley-Tilson W.H."/>
<person name="Deleault K.M."/>
<person name="Skinner S.J."/>
<person name="Gross R.H."/>
<person name="Whitfield M.L."/>
<person name="Brooks S.A."/>
</authorList>
<dbReference type="PubMed" id="18367721"/>
<dbReference type="DOI" id="10.1261/rna.748408"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="1999" last="2010">
<title>Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.</title>
<authorList>
<person name="Horner T.J."/>
<person name="Lai W.S."/>
<person name="Stumpo D.J."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="19188452"/>
<dbReference type="DOI" id="10.1128/mcb.00982-08"/>
</citation>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF CYS-124</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Growth Factors" volume="28" first="178" last="190">
<title>ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production.</title>
<authorList>
<person name="Hacker C."/>
<person name="Valchanova R."/>
<person name="Adams S."/>
<person name="Munz B."/>
</authorList>
<dbReference type="PubMed" id="20166898"/>
<dbReference type="DOI" id="10.3109/08977190903578660"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3340" last="3351">
<title>ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.</title>
<authorList>
<person name="Vignudelli T."/>
<person name="Selmi T."/>
<person name="Martello A."/>
<person name="Parenti S."/>
<person name="Grande A."/>
<person name="Gemelli C."/>
<person name="Zanocco-Marani T."/>
<person name="Ferrari S."/>
</authorList>
<dbReference type="PubMed" id="20702587"/>
<dbReference type="DOI" id="10.1091/mbc.e10-01-0040"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9588" last="E9588">
<title>Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.</title>
<authorList>
<person name="Kedar V.P."/>
<person name="Darby M.K."/>
<person name="Williams J.G."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="20221403"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009588"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HEAT SHOCK 70 KDA PROTEINS; MAP3K4; NCL; PABPC1 AND SH3KBP1</scope>
<scope>PHOSPHORYLATION AT SER-66 AND SER-93</scope>
<scope>RNA-BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PRO-309</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="3366" last="3378">
<title>Hypoxia-inducible factor-1alpha mRNA: a new target for destabilization by tristetraprolin in endothelial cells.</title>
<authorList>
<person name="Chamboredon S."/>
<person name="Ciais D."/>
<person name="Desroches-Castan A."/>
<person name="Savi P."/>
<person name="Bono F."/>
<person name="Feige J.J."/>
<person name="Cherradi N."/>
</authorList>
<dbReference type="PubMed" id="21775632"/>
<dbReference type="DOI" id="10.1091/mbc.e10-07-0617"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="256" last="266">
<title>Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.</title>
<authorList>
<person name="Clement S.L."/>
<person name="Scheckel C."/>
<person name="Stoecklin G."/>
<person name="Lykke-Andersen J."/>
</authorList>
<dbReference type="PubMed" id="21078877"/>
<dbReference type="DOI" id="10.1128/mcb.00717-10"/>
</citation>
<scope>MUTAGENESIS OF PHE-126</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Cell. Signal." volume="24" first="309" last="315">
<title>Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress.</title>
<authorList>
<person name="Holmes B."/>
<person name="Artinian N."/>
<person name="Anderson L."/>
<person name="Martin J."/>
<person name="Masri J."/>
<person name="Cloninger C."/>
<person name="Bernath A."/>
<person name="Bashir T."/>
<person name="Benavides-Serrato A."/>
<person name="Gera J."/>
</authorList>
<dbReference type="PubMed" id="21964062"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2011.09.015"/>
</citation>
<scope>INTERACTION WITH PRR5L</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-93; SER-186 AND SER-323</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="10037" last="10049">
<title>ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway.</title>
<authorList>
<person name="Adachi S."/>
<person name="Homoto M."/>
<person name="Tanaka R."/>
<person name="Hioki Y."/>
<person name="Murakami H."/>
<person name="Suga H."/>
<person name="Matsumoto M."/>
<person name="Nakayama K.I."/>
<person name="Hatta T."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
</authorList>
<dbReference type="PubMed" id="25106868"/>
<dbReference type="DOI" id="10.1093/nar/gku652"/>
</citation>
<scope>INTERACTION WITH CNOT7</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="Elife" volume="4" first="E03390" last="E03390">
<title>Post-transcriptional regulation of satellite cell quiescence by TTP-mediated mRNA decay.</title>
<authorList>
<person name="Hausburg M.A."/>
<person name="Doles J.D."/>
<person name="Clement S.L."/>
<person name="Cadwallader A.B."/>
<person name="Hall M.N."/>
<person name="Blackshear P.J."/>
<person name="Lykke-Andersen J."/>
<person name="Olwin B.B."/>
</authorList>
<dbReference type="PubMed" id="25815583"/>
<dbReference type="DOI" id="10.7554/elife.03390"/>
</citation>
<scope>FUNCTION</scope>
<scope>RNA-BINDING</scope>
<scope>MUTAGENESIS OF PHE-126</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2016" name="Amino Acids" volume="48" first="2303" last="2311">
<title>Destabilization of the ornithine decarboxylase mRNA transcript by the RNA-binding protein tristetraprolin.</title>
<authorList>
<person name="Nowotarski S.L."/>
<person name="Origanti S."/>
<person name="Sass-Kuhn S."/>
<person name="Shantz L.M."/>
</authorList>
<dbReference type="PubMed" id="27193233"/>
<dbReference type="DOI" id="10.1007/s00726-016-2261-9"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2016" name="Eur. J. Cell Biol." volume="95" first="277" last="284">
<title>Functional analysis of ZFP36 proteins in keratinocytes.</title>
<authorList>
<person name="Prenzler F."/>
<person name="Fragasso A."/>
<person name="Schmitt A."/>
<person name="Munz B."/>
</authorList>
<dbReference type="PubMed" id="27182009"/>
<dbReference type="DOI" id="10.1016/j.ejcb.2016.04.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="22449" last="22449">
<title>Interaction with pyruvate kinase M2 destabilizes tristetraprolin by proteasome degradation and regulates cell proliferation in breast cancer.</title>
<authorList>
<person name="Huang L."/>
<person name="Yu Z."/>
<person name="Zhang Z."/>
<person name="Ma W."/>
<person name="Song S."/>
<person name="Huang G."/>
</authorList>
<dbReference type="PubMed" id="26926077"/>
<dbReference type="DOI" id="10.1038/srep22449"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PKM</scope>
<scope>PHOSPHORYLATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-60</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="735" last="739">
<title>Structural basis for the recruitment of the human CCR4-NOT deadenylase complex by tristetraprolin.</title>
<authorList>
<person name="Fabian M.R."/>
<person name="Frank F."/>
<person name="Rouya C."/>
<person name="Siddiqui N."/>
<person name="Lai W.S."/>
<person name="Karetnikov A."/>
<person name="Blackshear P.J."/>
<person name="Nagar B."/>
<person name="Sonenberg N."/>
</authorList>
<dbReference type="PubMed" id="23644599"/>
<dbReference type="DOI" id="10.1038/nsmb.2572"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 312-326 IN COMPLEX WITH CNOT1</scope>
<scope>INTERACTION WITH CNOT1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-315 AND PHE-319</scope>
</reference>
<comment type="function">
<text evidence="4 7 8 9 10 11 12 16 17 18 19 22 24 25 26 27 28 30 31 33 35 37 38 39 40 41">Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:9703499, PubMed:10330172, PubMed:10751406, PubMed:11279239, PubMed:12115244, PubMed:12748283, PubMed:15187101, PubMed:15634918, PubMed:17030620, PubMed:16702957, PubMed:20702587, PubMed:20221403, PubMed:21775632, PubMed:27193233, PubMed:23644599, PubMed:25815583). Acts as an 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:15687258, PubMed:23644599). Recruits deadenylase CNOT7 (and probably the CCR4-NOT complex) via association with CNOT1, and hence promotes ARE-mediated mRNA deadenylation (PubMed:23644599). Functions also by recruiting components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs (PubMed:11719186, PubMed:12748283, PubMed:15687258, PubMed:16364915). Self regulates by destabilizing its own mRNA (PubMed:15187101). Binds to 3'-UTR ARE of numerous mRNAs and of its own mRNA (PubMed:10330172, PubMed:10751406, PubMed:12115244, PubMed:15187101, PubMed:15634918, PubMed:17030620, PubMed:16702957, PubMed:19188452, PubMed:20702587, PubMed:20221403, PubMed:21775632, PubMed:25815583). Plays a role in anti-inflammatory responses; suppresses tumor necrosis factor (TNF)-alpha production by stimulating ARE-mediated TNF-alpha mRNA decay and several other inflammatory ARE-containing mRNAs in interferon (IFN)- and/or lipopolysaccharide (LPS)-induced macrophages (By similarity). Plays also a role in the regulation of dendritic cell maturation at the post-transcriptional level, and hence operates as part of a negative feedback loop to limit the inflammatory response (PubMed:18367721). Promotes ARE-mediated mRNA decay of hypoxia-inducible factor HIF1A mRNA during the response of endothelial cells to hypoxia (PubMed:21775632). Positively regulates early adipogenesis of preadipocytes by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (By similarity). Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA (PubMed:20702587). Plays a role in maintaining skeletal muscle satellite cell quiescence by promoting ARE-mediated mRNA decay of the myogenic determination factor MYOD1 mRNA (By similarity). Associates also with and regulates the expression of non-ARE-containing target mRNAs at the post-transcriptional level, such as MHC class I mRNAs (PubMed:18367721). Participates in association with argonaute RISC catalytic components in the ARE-mediated mRNA decay mechanism; assists microRNA (miRNA) targeting ARE-containing mRNAs (PubMed:15766526). May also play a role in the regulation of cytoplasmic mRNA decapping; enhances decapping of ARE-containing RNAs, in vitro (PubMed:16364915). Involved in the delivery of target ARE-mRNAs to processing bodies (PBs) (PubMed:17369404). In addition to its cytosolic mRNA-decay function, affects nuclear pre-mRNA processing (By similarity). Negatively regulates nuclear poly(A)-binding protein PABPN1-stimulated polyadenylation activity on ARE-containing pre-mRNA during LPS-stimulated macrophages (By similarity). Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion (By similarity). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (PubMed:27182009). Plays a role as a tumor suppressor by inhibiting cell proliferation in breast cancer cells (PubMed:26926077).</text>
</comment>
<comment type="function">
<text evidence="13">(Microbial infection) Negatively regulates HTLV-1 TAX-dependent transactivation of viral long terminal repeat (LTR) promoter.</text>
</comment>
<comment type="subunit">
<text evidence="4 10 14 18 19 20 22 24 30 34 35 36 38">Associates with cytoplasmic CCR4-NOT and PAN2-PAN3 deadenylase complexes to trigger ARE-containing mRNA deadenylation and decay processes (By similarity). Part of a mRNA decay activation complex at least composed of poly(A)-specific exoribonucleases CNOT6, EXOSC2 and XRN1 and mRNA-decapping enzymes DCP1A and DCP2 (PubMed:15687258). Associates with the RNA exosome complex (PubMed:11719186). Interacts (via phosphorylated form) with 14-3-3 proteins; these interactions promote exclusion of ZFP36 from cytoplasmic stress granules in response to arsenite treatment in a MAPKAPK2-dependent manner and does not prevent CCR4-NOT deadenylase complex recruitment or ZFP36-induced ARE-containing mRNA deadenylation and decay processes (By similarity). Interacts with 14-3-3 proteins; these interactions occur in response to rapamycin in an Akt-dependent manner (PubMed:16702957). Interacts with AGO2 and AGO4 (PubMed:15766526). Interacts (via C-terminus) with CNOT1; this interaction occurs in a RNA-independent manner and induces mRNA deadenylation (PubMed:23644599). Interacts (via N-terminus) with CNOT6 (PubMed:15687258). Interacts with CNOT6L (By similarity). Interacts (via C-terminus) with CNOT7; this interaction occurs in a RNA-independent manner, induces mRNA deadenylation and is inhibited in a phosphorylation MAPKAPK2-dependent manner (PubMed:25106868). Interacts (via unphosphorylated form) with CNOT8; this interaction occurs in a RNA-independent manner and is inhibited in a phosphorylation MAPKAPK2-dependent manner (By similarity). Interacts with DCP1A (PubMed:15687258). Interacts (via N-terminus) with DCP2 (PubMed:15687258, PubMed:16364915). Interacts with EDC3 (PubMed:16364915). Interacts (via N-terminus) with EXOSC2 (PubMed:15687258). Interacts with heat shock 70 kDa proteins (PubMed:20221403). Interacts with KHSRP; this interaction increases upon cytokine-induced treatment (PubMed:16126846). Interacts with MAP3K4; this interaction enhances the association with SH3KBP1/CIN85 (PubMed:20221403). Interacts with MAPKAPK2; this interaction occurs upon skeletal muscle satellite cell activation (By similarity). Interacts with NCL (PubMed:20221403). Interacts with NUP214; this interaction increases upon lipopolysaccharide (LPS) stimulation (PubMed:14766228). Interacts with PABPC1; this interaction occurs in a RNA-dependent manner (PubMed:20221403). Interacts (via hypophosphorylated form) with PABPN1 (via RRM domain and C-terminal arginine-rich region); this interaction occurs in the nucleus in a RNA-independent manner, decreases in presence of single-stranded poly(A) RNA-oligomer and in a p38 MAPK-dependent-manner and inhibits nuclear poly(A) tail synthesis (By similarity). Interacts with PAN2 (By similarity). Interacts (via C3H1-type zinc finger domains) with PKM (PubMed:26926077). Interacts (via C3H1-type zinc finger domains) with nuclear RNA poly(A) polymerase (By similarity). Interacts with PPP2CA; this interaction occurs in LPS-stimulated cells and induces ZFP36 dephosphorylation, and hence may promote ARE-containing mRNAs decay (By similarity). Interacts (via C-terminus) with PRR5L (via C-terminus); this interaction may accelerate ZFP36-mediated mRNA decay during stress (PubMed:21964062). Interacts (via C-terminus) with SFN; this interaction occurs in a phosphorylation-dependent manner (By similarity). Interacts (via extreme C-terminal region) with SH3KBP1/CIN85 (via SH3 domains); this interaction enhances MAP3K4-induced phosphorylation of ZFP36 at Ser-66 and Ser-93 and does not alter neither ZFP36 binding to ARE-containing transcripts nor TNF-alpha mRNA decay (PubMed:20221403). Interacts with XRN1 (PubMed:15687258). Interacts (via C-terminus and Ser-186 phosphorylated form) with YWHAB; this interaction occurs in a p38/MAPKAPK2-dependent manner, increases cytoplasmic localization of ZFP36 and protects ZFP36 from Ser-186 dephosphorylation by serine/threonine phosphatase 2A, and hence may be crucial for stabilizing ARE-containing mRNAs (By similarity). Interacts (via phosphorylated form) with YWHAE (By similarity). Interacts (via C-terminus) with YWHAG; this interaction occurs in a phosphorylation-dependent manner (By similarity). Interacts with YWHAH; this interaction occurs in a phosphorylation-dependent manner (By similarity). Interacts with YWHAQ; this interaction occurs in a phosphorylation-dependent manner (By similarity). Interacts with (via C-terminus) YWHAZ; this interaction occurs in a phosphorylation-dependent manner (By similarity). Interacts (via P-P-P-P-G repeats) with GIGYF2; the interaction is direct (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="13">(Microbial infection) Interacts (via C-terminus) with HTLV-1 TAX (via C-terminus); this interaction inhibits HTLV-1 TAX to transactivate viral long terminal repeat (LTR) promoter (PubMed:14679154).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-374248">
<id>P26651</id>
</interactant>
<interactant intactId="EBI-16057352">
<id>A5YKK6-2</id>
<label>CNOT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-374248">
<id>P26651</id>
</interactant>
<interactant intactId="EBI-374238">
<id>Q9NPI6</id>
<label>DCP1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-374248">
<id>P26651</id>
</interactant>
<interactant intactId="EBI-997311">
<id>Q96F86</id>
<label>EDC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-374248">
<id>P26651</id>
</interactant>
<interactant intactId="EBI-741101">
<id>Q13643</id>
<label>FHL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-374248">
<id>P26651</id>
</interactant>
<interactant intactId="EBI-11984663">
<id>Q06455-2</id>
<label>RUNX1T1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15 39">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7 11 14 15 30">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cytoplasmic granule</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Cytoplasm</location>
<location evidence="26">P-body</location>
</subcellularLocation>
<text evidence="4 15 26 30">Shuttles between nucleus and cytoplasm in a CRM1-dependent manner (By similarity). Localized predominantly in the cytoplasm in a p38 MAPK- and YWHAB-dependent manner (By similarity). Colocalizes with SH3KBP1 and MAP3K4 in the cytoplasm (PubMed:20221403). Component of cytoplasmic stress granules (SGs) (By similarity). Localizes to cytoplasmic stress granules upon energy starvation (PubMed:15014438). Localizes in processing bodies (PBs) (PubMed:17369404). Excluded from stress granules in a phosphorylation MAPKAPK2-dependent manner (By similarity). Shuttles in and out of both cytoplasmic P-body and SGs (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Cytoplasm</location>
</subcellularLocation>
<text evidence="13">(Microbial infection) Colocalizes with HTLV-1 TAX in the nucleus and the cytoplasm in a region surrounding the nucleus.</text>
</comment>
<comment type="tissue specificity">
<text evidence="27 39">Expressed in both basal and suprabasal epidermal layers (PubMed:27182009). Expressed in epidermal keratinocytes (PubMed:27182009). Expressed strongly in mature dendritic cells (PubMed:18367721). Expressed in immature dendritic cells (at protein level) (PubMed:18367721).</text>
</comment>
<comment type="induction">
<text evidence="14 16 17 23 29 39">Up-regulated by T cell activation (PubMed:15634918). Up-regulated in keratinocytes in response to wounding (PubMed:27182009). Up-regulated by lipopolysaccharide (LPS) in a p38 MAPK- and ERK-dependent manner (at protein level) (PubMed:15187101, PubMed:16508015). Up-regulated strongly during epidermal repair after wounding in keratinocytes (PubMed:20166898). Up-regulated strongly by epidermal growth factor (EGF) and tumor necrosis factor (TNF-alpha) in keratinocytes (PubMed:20166898). Up-regulated moderately by granulocyte macrophage colony-stimulating factor (GM-CSF) and fibroblast growth factor (FGF1) in keratinocytes (PubMed:20166898). Up-regulated also by glucocorticoid dexamethasone in keratinocytes (PubMed:20166898). Up-regulated in keratinocytes in response to wounding (PubMed:27182009). Up-regulated by LPS in a p38 MAPK-dependent manner (PubMed:14766228, PubMed:15187101).</text>
</comment>
<comment type="domain">
<text evidence="7">The C3H1-type zinc finger domains are necessary for ARE-binding activity (PubMed:10330172).</text>
</comment>
<comment type="PTM">
<text evidence="4 24 30 38">Phosphorylated. Phosphorylation at serine and/or threonine residues occurs in a p38 MAPK- and MAPKAPK2-dependent manner (PubMed:16702957). Phosphorylated by MAPKAPK2 at Ser-60 and Ser-186; phosphorylation increases its stability and cytoplasmic localization, promotes binding to 14-3-3 adapter proteins and inhibits the recruitment of cytoplasmic CCR4-NOT and PAN2-PAN3 deadenylase complexes to the mRNA decay machinery, thereby inhibiting ZFP36-induced ARE-containing mRNA deadenylation and decay processes. Phosphorylation by MAPKAPK2 does not impair ARE-containing RNA-binding. Phosphorylated in a MAPKAPK2- and p38 MAPK-dependent manner upon skeletal muscle satellite cell activation; this phosphorylation inhibits ZFP36-mediated mRNA decay activity, and hence stabilizes MYOD1 mRNA (By similarity). Phosphorylated by MAPK1 upon mitogen stimulation (By similarity). Phosphorylated at Ser-66 and Ser-93; these phosphorylations increase in a SH3KBP1-dependent manner (PubMed:20221403). Phosphorylated at serine and threonine residues in a pyruvate kinase PKM- and p38 MAPK-dependent manner (PubMed:26926077). Phosphorylation at Ser-60 may participate in the PKM-mediated degradation of ZFP36 in a p38 MAPK-dependent manner (PubMed:26926077). Dephosphorylated by serine/threonine phosphatase 2A at Ser-186 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="38">Ubiquitinated; pyruvate kinase (PKM)-dependent ubiquitination leads to proteasomal degradation through a p38 MAPK signaling pathway (PubMed:26926077).</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/zfp36/"/>
</comment>
<dbReference type="EMBL" id="M92843">
<property type="protein sequence ID" value="AAA58489.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M92844">
<property type="protein sequence ID" value="AAC37600.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M63625">
<property type="protein sequence ID" value="AAA61240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314042">
<property type="protein sequence ID" value="BAG36751.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY771351">
<property type="protein sequence ID" value="AAV28731.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009693">
<property type="protein sequence ID" value="AAH09693.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12534.2"/>
<dbReference type="PIR" id="S34427">
<property type="entry name" value="S34427"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003398.2">
<property type="nucleotide sequence ID" value="NM_003407.3"/>
</dbReference>
<dbReference type="PDB" id="4J8S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="B=312-326"/>
</dbReference>
<dbReference type="PDBsum" id="4J8S"/>
<dbReference type="SMR" id="P26651"/>
<dbReference type="BioGRID" id="113370">
<property type="interactions" value="60"/>
</dbReference>
<dbReference type="CORUM" id="P26651"/>
<dbReference type="DIP" id="DIP-29845N"/>
<dbReference type="IntAct" id="P26651">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000469647"/>
<dbReference type="iPTMnet" id="P26651"/>
<dbReference type="PhosphoSitePlus" id="P26651"/>
<dbReference type="BioMuta" id="ZFP36"/>
<dbReference type="DMDM" id="136471"/>
<dbReference type="EPD" id="P26651"/>
<dbReference type="jPOST" id="P26651"/>
<dbReference type="MassIVE" id="P26651"/>
<dbReference type="PaxDb" id="P26651"/>
<dbReference type="PeptideAtlas" id="P26651"/>
<dbReference type="PRIDE" id="P26651"/>
<dbReference type="ProteomicsDB" id="54360"/>
<dbReference type="Antibodypedia" id="1121">
<property type="antibodies" value="336 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7538"/>
<dbReference type="Ensembl" id="ENST00000597629">
<property type="protein sequence ID" value="ENSP00000469647"/>
<property type="gene ID" value="ENSG00000128016"/>
</dbReference>
<dbReference type="GeneID" id="7538"/>
<dbReference type="KEGG" id="hsa:7538"/>
<dbReference type="CTD" id="7538"/>
<dbReference type="DisGeNET" id="7538"/>
<dbReference type="GeneCards" id="ZFP36"/>
<dbReference type="HGNC" id="HGNC:12862">
<property type="gene designation" value="ZFP36"/>
</dbReference>
<dbReference type="MIM" id="190700">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P26651"/>
<dbReference type="OpenTargets" id="ENSG00000128016"/>
<dbReference type="PharmGKB" id="PA37451"/>
<dbReference type="eggNOG" id="KOG1677">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162360"/>
<dbReference type="InParanoid" id="P26651"/>
<dbReference type="KO" id="K15308"/>
<dbReference type="OrthoDB" id="1541140at2759"/>
<dbReference type="PhylomeDB" id="P26651"/>
<dbReference type="TreeFam" id="TF315463"/>
<dbReference type="PathwayCommons" id="P26651"/>
<dbReference type="Reactome" id="R-HSA-450513">
<property type="pathway name" value="Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA"/>
</dbReference>
<dbReference type="SignaLink" id="P26651"/>
<dbReference type="SIGNOR" id="P26651"/>
<dbReference type="BioGRID-ORCS" id="7538">
<property type="hits" value="20 hits in 889 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ZFP36">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="ZFP36"/>
<dbReference type="GenomeRNAi" id="7538"/>
<dbReference type="Pharos" id="P26651">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P26651"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P26651">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P26651">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010494">
<property type="term" value="C:cytoplasmic stress granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000932">
<property type="term" value="C:P-body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019957">
<property type="term" value="F:C-C chemokine binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031072">
<property type="term" value="F:heat shock protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035925">
<property type="term" value="F:mRNA 3'-UTR AU-rich region binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070063">
<property type="term" value="F:RNA polymerase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061158">
<property type="term" value="P:3'-UTR-mediated mRNA destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070935">
<property type="term" value="P:3'-UTR-mediated mRNA stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044344">
<property type="term" value="P:cellular response to fibroblast growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071385">
<property type="term" value="P:cellular response to glucocorticoid stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097011">
<property type="term" value="P:cellular response to granulocyte macrophage colony-stimulating factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035278">
<property type="term" value="P:miRNA mediated inhibition of translation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006402">
<property type="term" value="P:mRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051028">
<property type="term" value="P:mRNA transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045647">
<property type="term" value="P:negative regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032703">
<property type="term" value="P:negative regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904246">
<property type="term" value="P:negative regulation of polynucleotide adenylyltransferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032897">
<property type="term" value="P:negative regulation of viral transcription"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000288">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031086">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, deadenylation-independent decay"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000289">
<property type="term" value="P:nuclear-transcribed mRNA poly(A) tail shortening"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038066">
<property type="term" value="P:p38MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901835">
<property type="term" value="P:positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000637">
<property type="term" value="P:positive regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904582">
<property type="term" value="P:positive regulation of intracellular mRNA localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900153">
<property type="term" value="P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060213">
<property type="term" value="P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902172">
<property type="term" value="P:regulation of keratinocyte apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045616">
<property type="term" value="P:regulation of keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010837">
<property type="term" value="P:regulation of keratinocyte proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032680">
<property type="term" value="P:regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042594">
<property type="term" value="P:response to starvation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009611">
<property type="term" value="P:response to wounding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="IDEAL" id="IID00655"/>
<dbReference type="InterPro" id="IPR000571">
<property type="entry name" value="Znf_CCCH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036855">
<property type="entry name" value="Znf_CCCH_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00642">
<property type="entry name" value="zf-CCCH"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00356">
<property type="entry name" value="ZnF_C3H1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90229">
<property type="entry name" value="SSF90229"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50103">
<property type="entry name" value="ZF_C3H1"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0271">Exosome</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0509">mRNA transport</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0687">Ribonucleoprotein</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0943">RNA-mediated gene silencing</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="mRNA decay activator protein ZFP36" id="PRO_0000089163">
<location>
<begin position="1"/>
<end position="326"/>
</location>
</feature>
<feature type="repeat" description="P-P-P-P-G">
<location>
<begin position="71"/>
<end position="75"/>
</location>
</feature>
<feature type="repeat" description="P-P-P-P-G">
<location>
<begin position="198"/>
<end position="202"/>
</location>
</feature>
<feature type="repeat" description="P-P-P-P-G">
<location>
<begin position="219"/>
<end position="223"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 1" evidence="6">
<location>
<begin position="103"/>
<end position="131"/>
</location>
</feature>
<feature type="zinc finger region" description="C3H1-type 2" evidence="6">
<location>
<begin position="141"/>
<end position="169"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for localization of ARE-containing mRNAs to processing bodies (PBs)" evidence="26">
<location>
<begin position="1"/>
<end position="174"/>
</location>
</feature>
<feature type="region of interest" description="Necessary and sufficient for the association with mRNA decay enzymes and mRNA decay activation" evidence="18">
<location>
<begin position="1"/>
<end position="100"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for nuclear export" evidence="5">
<location>
<begin position="1"/>
<end position="15"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for nuclear localization" evidence="5">
<location>
<begin position="95"/>
<end position="168"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for RNA-binding" evidence="8 12">
<location>
<begin position="97"/>
<end position="173"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for localization of ARE-containing mRNAs to processing bodies (PBs)" evidence="26">
<location>
<begin position="100"/>
<end position="326"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with PABPN1" evidence="4">
<location>
<begin position="103"/>
<end position="194"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for mRNA decay activation" evidence="18">
<location>
<begin position="174"/>
<end position="326"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CNOT1" evidence="35">
<location>
<begin position="312"/>
<end position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK2" evidence="4">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21 30">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="21">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 30">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK2" evidence="2 3 21">
<location>
<position position="186"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="197"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1; in vitro" evidence="21">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="276"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17878633." id="VAR_021064" evidence="42">
<original>P</original>
<variation>S</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229272." id="VAR_052324">
<original>P</original>
<variation>S</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17886974." id="VAR_021065" evidence="42">
<original>I</original>
<variation>F</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17884899." id="VAR_021066" evidence="42">
<original>V</original>
<variation>F</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits PKM-induced ZFP36 degradation through a p38 MAPK signaling pathway." evidence="38">
<original>S</original>
<variation>A</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits binding to ARE-containing transcripts. Inhibits binding to and deadenylation activities of ARE-containing mRNAs. Inhibits localization of ARE-containing mRNAs to processing bodies (PBs)." evidence="7 12 25 26 28">
<original>C</original>
<variation>R</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits ARE-containing RNA-binding, deadenylation and RNA decapping activities." evidence="22 32 37">
<original>F</original>
<variation>N</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits both ARE-binding and mRNA deadenylation activities." evidence="7">
<original>C</original>
<variation>R</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with SH3KBP1." evidence="30">
<original>P</original>
<variation>V</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CNOT1." evidence="35">
<original>R</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CNOT1 and impairs TNF mRNA deadenylation." evidence="35">
<original>F</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="317"/>
<end position="322"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4J8S"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P22893"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P47973"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00723"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10330172"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10751406"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11279239"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719186"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12115244"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12748283"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14679154"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14766228"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15014438"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15187101"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15634918"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15687258"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15766526"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16126846"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16262601"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16364915"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16508015"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16702957"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17030620"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17369404"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18367721"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19188452"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20166898"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20221403"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20702587"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21078877"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21775632"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21964062"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23644599"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25106868"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25815583"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26926077"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27182009"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27193233"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9703499"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2062660"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<evidence key="45" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:12862"/>
</source>
</evidence>
<sequence length="326" mass="34003" checksum="DDD9AD950AF7AF98" modified="1992-08-01" version="1">MDLTAIYESLLSLSPDVPVPSDHGGTESSPGWGSSGPWSLSPSDSSPSGVTSRLPGRSTSLVEGRSCGWVPPPPGFAPLAPRLGPELSPSPTSPTATSTTPSRYKTELCRTFSESGRCRYGAKCQFAHGLGELRQANRHPKYKTELCHKFYLQGRCPYGSRCHFIHNPSEDLAAPGHPPVLRQSISFSGLPSGRRTSPPPPGLAGPSLSSSSFSPSSSPPPPGDLPLSPSAFSAAPGTPLARRDPTPVCCPSCRRATPISVWGPLGGLVRTPSVQSLGSDPDEYASSGSSLGGSDSPVFEAGVFAPPQPVAAPRRLPIFNRISVSE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

